Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects

ConclusionOur results clearly demonstrate that the frequency of CYP3A5*3 splicing variant is higher in myopathy group than in the tolerant group. We did not find significant association of genetic polymorphisms in CYP3A5, COQ, and SLCO1B1 with atorvastatin- or rosuvastatin-induced myopathy.
Source: Indian Heart Journal - Category: Cardiology Source Type: research